Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-25 @ 2:30 AM
NCT ID:
NCT02845934
Eligibility Criteria:
Inclusion Criteria:
* Suspicion of invasive mould infection
* in a patient at high risk according to the EORTC/MSG criteria updated in 2008 (patients with prolonged severe neutropenia, receiving corticosteroids or T-cell suppressor, recipients of allogeneic HSCT, or inherited severe immunodeficiency)
* or in a patient with other predisposing factors of invasive mould disease ( diabetes, AIDS, haematological malignancies or solid tumours, trauma, burns).
* Patients already diagnosed with probable or proven mucormycosis irrespective of underlying conditions, including patients referred from other centers.
* Only adult patients (18 years or older) will be included
Exclusion Criteria:
* Age : under 18 years
* Patients previously included in the trial with a diagnosis of mucormycosis. However patients previously entered in the trial with a diagnosis other than mucormycosis will be eligible for re- new inclusion.
* Presence of any medical condition that would not allow collection of blood samples for the qPCR test.
* History of documented, successfully treated, prior mucormycosis.
* protected people (pregnant women, minor, guardianship…)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02845934
Study Brief:
Protocol Section:
NCT02845934